Heritage Bio Labs
Research Library
Explore 411 articles about peptides, research compounds and related topics, with links to the original studies.
Find articles
All articles
Showing 313–324 of 411 articles
- Check methods and identity
What the first TRANSCEND diabetes trial measured
Retatrutide is an investigational peptide that acts at GIP, GLP-1 and glucagon receptors. The catalog’s “GLP-3” wording describes this entry rather than a receptor.
RETA GLP-32 sources (2026)
- Explore study findings
What retatrutide blood samples reveal about changing fuel use
Retatrutide is an investigational peptide that activates the GIP, GLP-1 and glucagon receptors. The “GLP-3” label refers to the catalog entry.
RETA GLP-31 source (2026)
- Explore study findings
What a retatrutide outcomes trial can establish about kidney events
Retatrutide is an investigational peptide that acts on GIP, GLP-1 and glucagon receptors. IGF-1 LR3 is an engineered, extended version of the insulin-like growth factor 1 protein. This catalog entry names the two together.
RETA / IGF-1 LR33 sources (1995–2026)
- Interpret the evidence
Why glucose averages leave a combination safety question open
Retatrutide is an investigational peptide that activates GIP, GLP-1 and glucagon receptors. IGF-1 LR3 is a modified growth-factor protein with an extended amino-acid sequence.
RETA / IGF-1 LR33 sources (1997–2026)
- Interpret the evidence
What a different retatrutide combination taught researchers about study design
Retatrutide is an investigational GIP, GLP-1 and glucagon receptor agonist. IGF-1 LR3 is a modified, extended insulin-like growth factor protein. The exact pair in this entry is separate from a 2026 rat experiment that tested retatrutide with cagrilintide, an amylin-based peptide.
RETA / IGF-1 LR32 sources (1992, 2026)
- Check methods and identity
What the lab would have to verify about a preparation with both molecules
Retatrutide is an investigational peptide with activity at GIP, GLP-1 and glucagon receptors. IGF-1 LR3 is an engineered insulin-like growth factor protein. Research about making each material provides background for asking how scientists would verify a preparation containing both.
RETA / IGF-1 LR33 sources (2023, 2026)
- Interpret the evidence
Why a body scan leaves a separate question about muscle function
Retatrutide is an investigational peptide that activates GIP, GLP-1 and glucagon receptors. IGF-1 LR3 is an engineered form of insulin-like growth factor 1. An older retatrutide substudy used body scans to distinguish changes in fat from changes in lean tissue.
RETA / IGF-1 LR32 sources (1997, 2025)
- Understand the science
What growth-factor binding proteins change in a laboratory experiment
Retatrutide activates GIP, GLP-1 and glucagon receptors and remains investigational. IGF-1 LR3 is a modified, extended form of insulin-like growth factor 1. An older experiment in cultured ovarian support cells shows why the modified form is treated as its own research material.
RETA / IGF-1 LR32 sources (1992, 2026)
- Check methods and identity
What the Early Selank Comparisons Measured About Anxiety
Selank is a synthetic seven-amino-acid peptide modeled on a peptide called tuftsin. It has been investigated in anxiety research. The direct clinical comparisons described here are older: a search of recent indexed articles did not identify a newer original trial that answered the same question.
Selank2 sources (2008, 2014)
- Interpret the evidence
Why a Blood Marker Could Not Establish How Selank Works in the Brain
Selank is a synthetic seven-amino-acid analog of the naturally occurring peptide tuftsin. In an older clinical comparison, investigators measured a blood marker related to an endogenous peptide alongside anxiety symptoms.
Selank1 source (2008)
- Explore study findings
What a Selank Rat Study Found About GABA Related Gene Expression
Selank is a synthetic peptide based on tuftsin. It has been studied in relation to GABA, a neurotransmitter that participates in regulating nervous system activity. An older laboratory study tested whether gene expression in rat brain tissue changed after exposure to Selank.
Selank1 source (2016)
- Check methods and identity
What Brain Connectivity Imaging Can Tell Us About Selank
Selank is a synthetic peptide modeled on tuftsin. An older study investigated whether Selank or a different peptide, Semax, changed patterns on brain scans in healthy volunteers. Its measurements were about brain activity at rest.
Selank1 source (2020)
Browse by product
- A4 Amyloid Beta6 articles
- ACE-0316 articles
- ACE-0836 articles
- Adipotide6 articles
- AICAR6 articles
- AOD-96046 articles
- ARA-2906 articles
- BPC-1576 articles
- BPC-157 / TB-5006 articles
- Cagrilintide7 articles
- CJC-1295 (No DAC) / GHRP-26 articles
- CJC-1295 (No DAC) / GHRP-66 articles
- CJC-1295 (No DAC) / Ipamorelin6 articles
- CJC-1295 No DAC6 articles
- CJC-1295 With DAC6 articles
- DSIP6 articles
- Epitalon6 articles
- Follistatin 3156 articles
- Follistatin 3446 articles
- Fragment 176-1916 articles
- GHK-Cu6 articles
- GHRP-26 articles
- GHRP-66 articles
- GLOW 2 Blend6 articles
- GLOW Blend6 articles
- GLP-1 SEMA6 articles
- GLP-2 TIRZ6 articles
- Glutathione6 articles
- HCG6 articles
- Hexarelin6 articles
- Human Relaxin-26 articles
- IGF-1 DES 1,36 articles
- IGF-1 Human6 articles
- IGF-2 LR36 articles
- IGF-DES 1,36 articles
- IGF-LR36 articles
- Ipamorelin6 articles
- Kisspeptin-106 articles
- KLOW Blend6 articles
- KPV6 articles
- Lipopeptide6 articles
- Liraglutide6 articles
- Melanotan II5 articles
- MGF6 articles
- MOTS-C6 articles
- MSC Exosomes6 articles
- Myostatin6 articles
- Myostatin HMP (GDF8)6 articles
- Oxytocin7 articles
- PEG-MGF6 articles
- Pinealon6 articles
- PT-1416 articles
- RETA / IGF-1 LR36 articles
- RETA GLP-36 articles
- Selank6 articles
- SEMA / IGF-1 LR36 articles
- Semax6 articles
- Sermorelin6 articles
- SLU-PP-3326 articles
- SNAP-86 articles
- Survodutide7 articles
- TB-5006 articles
- Tesamorelin6 articles
- Thymosin Alpha-16 articles
- TIRZ / IGF-1 LR36 articles
- TIRZ GLP-26 articles
- Trevogrumab6 articles
- Triptorelin GnRH6 articles
